Secondary infections in COVID-19: Antemortem and postmortem culture study

Vandana V Kiro1, Meenakshi Sharma2, Sharad Srivastava3

  • 1Department of Microbiology, Division of Forensic Pathology and Molecular DNA, New Delhi, India.

Abstract

Insights

Secondary bacterial infections in hospitalized COVID-19 patients were studied. Resistant pathogens like Acinetobacter baumannii and Klebsiella pneumoniae were identified in both living and deceased patients, suggesting a role in mortality.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Critical Care Medicine

Background:

  • Secondary bacterial infections complicate COVID-19 hospitalizations in 6-15% of patients.
  • Understanding these infections is crucial for patient outcomes.

Purpose of the Study:

  • To investigate secondary bacterial infections in hospitalized COVID-19 patients.
  • To determine the bacteriological profile of samples from deceased COVID-19 patients.

Main Methods:

  • Prospective study conducted at a tertiary care center in North India (July 2020 - April 2021).
  • Analysis of 268 patient samples (antemortem and postmortem), including nasopharyngeal swabs, blood, tissue, urine, and cerebrospinal fluid.

Main Results:

  • Identified common pathogens: Acinetobacter baumannii (43.1% antemortem, 44.1% postmortem), Klebsiella pneumoniae (36.3% antemortem, 25.5% postmortem), and Escherichia coli (11.3% antemortem, 20.9% postmortem).
  • All isolated pathogens exhibited high antimicrobial resistance.
  • Bacterial profiles were similar in antemortem and postmortem samples.

Conclusions:

  • Similar bacterial profiles in antemortem and postmortem samples suggest a link between resistant pathogens and COVID-19 mortality.
  • Highlights the significant burden of antimicrobial-resistant infections in severe COVID-19 cases.